Skip to main content
Top
Published in: Journal of Neurology 12/2019

01-12-2019 | Anticoagulant | Letter to the Editors

High-dose steroid therapy for CNS inflammatory diseases increases INR in patients taking oral vitamin K antagonist

Authors: Stefano Gelibter, Mario Orrico, Tommaso Croese, Luca Bosco, Vittorio Martinelli, Francesca Sangalli, Massimo Filippi

Published in: Journal of Neurology | Issue 12/2019

Login to get access

Excerpt

Dear Sirs, …
Literature
1.
go back to reference Kaufman M (1997) Treatment of multiple sclerosis with high-dose corticosteroids may prolong the prothrombin time to dangerous levels in patients taking warfarin. Mult Scler 3:248–249CrossRef Kaufman M (1997) Treatment of multiple sclerosis with high-dose corticosteroids may prolong the prothrombin time to dangerous levels in patients taking warfarin. Mult Scler 3:248–249CrossRef
2.
go back to reference Costedoat-Chalumeau N, Amoura Z, Aymard G et al (2000) Potentiation of Vitamin K antagonists by high-dose intravenous methylprednisolone. Ann Intern Med 132:631–635CrossRef Costedoat-Chalumeau N, Amoura Z, Aymard G et al (2000) Potentiation of Vitamin K antagonists by high-dose intravenous methylprednisolone. Ann Intern Med 132:631–635CrossRef
Metadata
Title
High-dose steroid therapy for CNS inflammatory diseases increases INR in patients taking oral vitamin K antagonist
Authors
Stefano Gelibter
Mario Orrico
Tommaso Croese
Luca Bosco
Vittorio Martinelli
Francesca Sangalli
Massimo Filippi
Publication date
01-12-2019
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 12/2019
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-019-09515-6

Other articles of this Issue 12/2019

Journal of Neurology 12/2019 Go to the issue